Phase 2 Pragmatic Trial of Sentinel Lymph Node Biopsy (SLNB) in Patients With Clinically Node-Negative (cN0), High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) of the Head and Neck
Abroad (travel likely)RecruitingPHASE2
Conditions
Cutaneous Squamous Cell Carcinoma of the Head and Neck · Clinically Node-Negative (cN0) · High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) of the Head and Neck
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of California, Davis, Sacramento, California, United States
Study leads
Andrew Birkeland, MD
Principal Investigator
University of California, Davis